Key result
Counting footsteps using a pedometer for 9 weeks significantly increased HMW-adiponectin (3.77 vs. 3.80 μg/ml, p=0.034) and improved metabolic syndrome components in young females with high BMI.
Why the study?
Physical activity may improve cardiometabolic fitness and increase high-molecular-weight adiponectin, but the effect of counting footsteps with a pedometer on HMW-Adip and metabolic syndrome components in young females needed examination.
Does counting footsteps with a pedometer improve HMW adiponectin and metabolic syndrome components in young female adults?
Does counting footsteps with a pedometer improve HMW adiponectin and metabolic syndrome components in young female adults?
Counting footsteps with a pedometer for 9 weeks improves metabolic syndrome components and increases high-molecular-weight adiponectin in young females, particularly those with a high BMI.
May increase HMW-adiponectin in high-BMI young women; hypothesis-generating and requires RCTs before practice change.
Introduction . Physical activity (PA) may improve cardiometabolic fitness and increase high-molecular-weight adiponectin (HMW-Adip). The pedometer is an effective, user-friendly device to monitor PA with the aim of improving health. This study examined how counting footsteps, using a pedometer, might affect HMW-Adip and MetS components among young females. Methods . Fifty-two females (21.43 ± 4.8 years) were divided into “normal” (BMI = 18–24.9 kg/m 2 ) and “high” (BMI ≥ 25 kg/m 2 ) BMI groups. Participants wore pedometers throughout the day for nine weeks. Pre-post intervention tests performed on anthropometric, biochemical, and nutrient intake variables were tested atp≤0.05. Results . Participants walked 7056 ± 1570 footsteps/day without a significant difference between normal (7488.49 ± 1098) and high (6739.18 ± 1793) BMI groups. After week 9, the normal BMI group improved significantly in BMI, body fat mass (BFM), and waist-hip ratio (WHR). Additionally, percent body fat, waist circumference (WC), and visceral fat area also reduced significantly in the high BMI group. A significant decrease in triglycerides (TG) (71.62 ± 29.22 vs. 62.50 ± 29.16 mg/dl,p=0.003) and insulin (21.7 ± 8.33 µ U/l vs. 18.64 ± 8.25 µ U/l,p=0.046) and increase in HMW-Adip (3.77 ± 0.46 vs. 3.80 ± 0.44 μ g/ml,p=0.034) were recorded in the high BMI group. All participants exhibited significant inverse correlations between daily footsteps and BMI (r=−0.33, p=0.017), BFM (r=−0.29, p=0.037), WHR (r=−0.401, p=0.003), and MetS score (r=−0.49, p<0.001) and positive correlation with HMW-Adip (r=0.331, p=0.017). A positive correlation with systolic (r=0.46, p=0.011) and diastolic (r=0.39, p=0.031) blood pressures and inverse correlation with the MetS score (r=−0.5, p=0.005) were evident in the high BMI group. Conclusion . Counting footsteps using a pedometer is effective in improving MetS components (obesity, TG) and increasing HMW-Adip levels.
No takes yet. Share an insight, caveat, or question.
Hasan et al. (2018) studied High BMI and Metabolic Syndrome (n=52). Counting footsteps using a pedometer vs. Pre-intervention baseline was evaluated on High-molecular-weight adiponectin (HMW-Adip) in the high BMI group (p=0.034). Counting footsteps using a pedometer for 9 weeks significantly increased HMW-adiponectin (3.77 vs. 3.80 μg/ml, p=0.034) and improved metabolic syndrome components in young females with high BMI.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: